Free Trial

Zentek (CVE:ZEN) Share Price Passes Below 200 Day Moving Average - What's Next?

Zentek logo with Medical background

Key Points

  • Zentek Ltd. shares fell below their 200-day moving average of C$1.52, trading as low as C$1.00 before closing at C$1.05.
  • The company has a market capitalization of C$109.95 million and a P/E ratio of -13.13, indicating potential challenges in profitability.
  • Zentek is involved in the research and development of graphene-based products, including antimicrobial coatings and personal protective equipment.
  • Interested in Zentek? Here are five stocks we like better.

Zentek Ltd. (CVE:ZEN - Get Free Report)'s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of C$1.52 and traded as low as C$1.00. Zentek shares last traded at C$1.05, with a volume of 135,278 shares changing hands.

Zentek Stock Performance

The stock has a market capitalization of C$109.95 million, a P/E ratio of -13.13 and a beta of 0.39. The company has a quick ratio of 7.59, a current ratio of 2.06 and a debt-to-equity ratio of 4.97. The business has a fifty day moving average price of C$1.13 and a 200-day moving average price of C$1.52.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.